A detailed history of Td Asset Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Td Asset Management Inc holds 1,084,713 shares of EW stock, worth $73.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,084,713
Previous 1,414,865 23.33%
Holding current value
$73.5 Million
Previous $131 Million 45.23%
% of portfolio
0.07%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$59.7 - $93.78 $19.7 Million - $31 Million
-330,152 Reduced 23.33%
1,084,713 $71.6 Million
Q2 2024

Aug 02, 2024

SELL
$84.3 - $94.31 $4.08 Million - $4.57 Million
-48,443 Reduced 3.31%
1,414,865 $131 Million
Q1 2024

May 08, 2024

BUY
$72.54 - $95.56 $10.1 Million - $13.3 Million
139,697 Added 10.55%
1,463,308 $140 Million
Q4 2023

Feb 12, 2024

BUY
$61.71 - $77.76 $39.8 Million - $50.2 Million
645,204 Added 95.11%
1,323,611 $101 Million
Q3 2023

Oct 27, 2023

BUY
$69.28 - $93.38 $7.54 Million - $10.2 Million
108,904 Added 19.12%
678,407 $47 Million
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $2.2 Million - $2.55 Million
-27,020 Reduced 4.53%
569,503 $53.7 Million
Q1 2023

May 10, 2023

SELL
$74.26 - $84.51 $265,108 - $301,700
-3,570 Reduced 0.59%
596,523 $49.4 Million
Q4 2022

Feb 06, 2023

BUY
$68.3 - $87.44 $15.2 Million - $19.5 Million
223,128 Added 59.19%
600,093 $44.8 Million
Q3 2022

Nov 07, 2022

BUY
$82.37 - $107.29 $450,811 - $587,198
5,473 Added 1.47%
376,965 $31.6 Million
Q2 2022

Aug 04, 2022

SELL
$86.5 - $128.27 $677,554 - $1 Million
-7,833 Reduced 2.06%
371,492 $35.3 Million
Q1 2022

May 10, 2022

BUY
$101.96 - $128.34 $108,485 - $136,553
1,064 Added 0.28%
379,325 $44.7 Million
Q4 2021

Feb 10, 2022

SELL
$106.37 - $130.68 $1.96 Million - $2.4 Million
-18,390 Reduced 4.64%
378,261 $49 Million
Q3 2021

Nov 09, 2021

SELL
$102.91 - $122.75 $211,685 - $252,496
-2,057 Reduced 0.52%
396,651 $44.9 Million
Q2 2021

Aug 11, 2021

SELL
$83.84 - $104.76 $1.09 Million - $1.36 Million
-13,029 Reduced 3.16%
398,708 $44.8 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $2.55 Million - $2.94 Million
32,459 Added 8.56%
411,737 $34.4 Million
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $175,568 - $223,422
2,449 Added 0.65%
379,278 $34.6 Million
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $9.74 Million - $12.7 Million
144,979 Added 62.53%
376,829 $30.1 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $8.83 Million - $11.8 Million
153,438 Added 195.68%
231,850 $16 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $233,801 - $361,341
4,461 Added 6.03%
78,412 $14.8 Million
Q4 2019

Feb 11, 2020

SELL
$71.7 - $82.09 $472,359 - $540,808
-6,588 Reduced 8.18%
73,951 $17.3 Million
Q3 2019

Nov 07, 2019

SELL
$61.55 - $75.43 $186,311 - $228,326
-3,027 Reduced 3.62%
80,539 $17.7 Million
Q2 2019

Aug 01, 2019

SELL
$55.74 - $64.41 $114,545 - $132,362
-2,055 Reduced 2.4%
83,566 $15.4 Million
Q1 2019

May 08, 2019

SELL
$47.89 - $64.05 $82,131 - $109,845
-1,715 Reduced 1.96%
85,621 $16.4 Million
Q4 2018

Feb 01, 2019

BUY
$46.41 - $56.94 $134,356 - $164,841
2,895 Added 3.43%
87,336 $13.4 Million
Q3 2018

Nov 01, 2018

BUY
$45.7 - $58.03 $98,072 - $124,532
2,146 Added 2.61%
84,441 $14.7 Million
Q2 2018

Jul 31, 2018

BUY
$42.45 - $51.3 $98,823 - $119,426
2,328 Added 2.91%
82,295 $12 Million
Q1 2018

May 11, 2018

SELL
$37.19 - $47.45 $36,371 - $46,406
-978 Reduced 1.21%
79,967 $11.2 Million
Q4 2017

Feb 02, 2018

BUY
$33.79 - $39.39 $40,615 - $47,346
1,202 Added 1.51%
80,945 $9.12 Million
Q3 2017

Nov 09, 2017

BUY
$36.29 - $38.83 $2.89 Million - $3.1 Million
79,743
79,743 $8.72 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.